Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MegaLT Injection for Platelet Recovery After Umbilical Cord Blood Transplantation
NCT07696767Phase 1Not yet recruiting
- Sponsor
- The First Affiliated Hospital of USTC
- Start
- Jul 2026
- Primary completion
- Dec 2026
01
Overview
Phase 1, open-label, single-arm trial of MegaLT in Thrombocytopenia, sponsored by The First Affiliated Hospital of USTC. Primary endpoints: Time to Platelet Engraftment at 6 months and Platelet Engraftment by Day 28. Planned start Jul 2026; status: not yet recruiting.
02
Drugs
MegaLT
03
Conditions
Thrombocytopenia
Beyond the preview
Go deeper on NCT07696767.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07696767.